BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26453549)

  • 1. Intrinsic factors and the embryonic environment influence the formation of extragonadal teratomas during gestation.
    Economou C; Tsakiridis A; Wymeersch FJ; Gordon-Keylock S; Dewhurst RE; Fisher D; Medvinsky A; Smith AJ; Wilson V
    BMC Dev Biol; 2015 Oct; 15():35. PubMed ID: 26453549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct developmental ground states of epiblast stem cell lines determine different pluripotency features.
    Bernemann C; Greber B; Ko K; Sterneckert J; Han DW; Araúzo-Bravo MJ; Schöler HR
    Stem Cells; 2011 Oct; 29(10):1496-503. PubMed ID: 21898681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The developmental dismantling of pluripotency is reversed by ectopic Oct4 expression.
    Osorno R; Tsakiridis A; Wong F; Cambray N; Economou C; Wilkie R; Blin G; Scotting PJ; Chambers I; Wilson V
    Development; 2012 Jul; 139(13):2288-98. PubMed ID: 22669820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of co-expression of OCT4, NANOG and SOX2 in pluripotent cells of the porcine embryo, in vivo and in vitro.
    du Puy L; Lopes SM; Haagsman HP; Roelen BA
    Theriogenology; 2011 Feb; 75(3):513-26. PubMed ID: 21074831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oct4 regulates the embryonic axis and coordinates exit from pluripotency and germ layer specification in the mouse embryo.
    Mulas C; Chia G; Jones KA; Hodgson AC; Stirparo GG; Nichols J
    Development; 2018 Jun; 145(12):. PubMed ID: 29915126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [OCT4 and NANOG are the key genes in the system of pluripotency maintenance in mammalian cells].
    Medvedev SP; Shevchenko AI; Mazurok NA; Zakiian SM
    Genetika; 2008 Dec; 44(12):1589-608. PubMed ID: 19178078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprogramming of human somatic cells to pluripotency with defined factors.
    Park IH; Zhao R; West JA; Yabuuchi A; Huo H; Ince TA; Lerou PH; Lensch MW; Daley GQ
    Nature; 2008 Jan; 451(7175):141-6. PubMed ID: 18157115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zic3 enhances the generation of mouse induced pluripotent stem cells.
    Declercq J; Sheshadri P; Verfaillie CM; Kumar A
    Stem Cells Dev; 2013 Jul; 22(14):2017-25. PubMed ID: 23421367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation of pluripotent stem cells from nascent undifferentiated teratoma.
    An Y; Sekinaka T; Tando Y; Okamura D; Tanaka K; Ito-Matsuoka Y; Takehara A; Yaegashi N; Matsui Y
    Dev Biol; 2019 Feb; 446(1):43-55. PubMed ID: 30529251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression Nanog activates pluripotent genes in porcine fetal fibroblasts and nuclear transfer embryos.
    Zhang L; Luo YB; Bou G; Kong QR; Huan YJ; Zhu J; Wang JY; Li H; Wang F; Shi YQ; Wei YC; Liu ZH
    Anat Rec (Hoboken); 2011 Nov; 294(11):1809-17. PubMed ID: 21972213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conserved long noncoding RNAs transcriptionally regulated by Oct4 and Nanog modulate pluripotency in mouse embryonic stem cells.
    Sheik Mohamed J; Gaughwin PM; Lim B; Robson P; Lipovich L
    RNA; 2010 Feb; 16(2):324-37. PubMed ID: 20026622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous overexpression of Oct4 and Nanog abrogates terminal myogenesis.
    Lang KC; Lin IH; Teng HF; Huang YC; Li CL; Tang KT; Chen SL
    Am J Physiol Cell Physiol; 2009 Jul; 297(1):C43-54. PubMed ID: 19403798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oct4 is required for lineage priming in the developing inner cell mass of the mouse blastocyst.
    Le Bin GC; Muñoz-Descalzo S; Kurowski A; Leitch H; Lou X; Mansfield W; Etienne-Dumeau C; Grabole N; Mulas C; Niwa H; Hadjantonakis AK; Nichols J
    Development; 2014 Mar; 141(5):1001-10. PubMed ID: 24504341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of ground-state pluripotency by allelic regulation of Nanog.
    Miyanari Y; Torres-Padilla ME
    Nature; 2012 Feb; 483(7390):470-3. PubMed ID: 22327294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oct4 is required ~E7.5 for proliferation in the primitive streak.
    DeVeale B; Brokhman I; Mohseni P; Babak T; Yoon C; Lin A; Onishi K; Tomilin A; Pevny L; Zandstra PW; Nagy A; van der Kooy D
    PLoS Genet; 2013 Nov; 9(11):e1003957. PubMed ID: 24244203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethyl-p-methoxycinnamate enhances oct4 expression and reinforces pluripotency through the NF-κB signaling pathway.
    Ai H; Qin H; Li J; Niu C; Song Z; Bao Y; Sun L; Zheng L; Li Y
    Biochem Pharmacol; 2020 Jul; 177():113984. PubMed ID: 32311348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genetic and developmental pathway from STAT3 to the OCT4-NANOG circuit is essential for maintenance of ICM lineages in vivo.
    Do DV; Ueda J; Messerschmidt DM; Lorthongpanich C; Zhou Y; Feng B; Guo G; Lin PJ; Hossain MZ; Zhang W; Moh A; Wu Q; Robson P; Ng HH; Poellinger L; Knowles BB; Solter D; Fu XY
    Genes Dev; 2013 Jun; 27(12):1378-90. PubMed ID: 23788624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primed pluripotent cell lines derived from various embryonic origins and somatic cells in pig.
    Park JK; Kim HS; Uh KJ; Choi KH; Kim HM; Lee T; Yang BC; Kim HJ; Ka HH; Kim H; Lee CK
    PLoS One; 2013; 8(1):e52481. PubMed ID: 23326334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG.
    Li Y; Zhao H; Lan F; Lee A; Chen L; Lin C; Yao Y; Li L
    Cell Reprogram; 2010 Jun; 12(3):237-47. PubMed ID: 20698766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of three stem cell lines from human sacrococcygeal teratomas.
    Busch C; Bareiss PM; Sinnberg T; Just L; Wehrmann M; Fuchs J; Garbe C; Drews U
    J Pathol; 2009 Mar; 217(4):589-96. PubMed ID: 19142973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.